- Home
- NUWE vs DRMA Comparison
NUWE vs DRMA Comparison
Compare NUWE & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- DRMA
- Stock Information
- Founded
- NUWE 1999
- DRMA 2014
- Country
- NUWE United States
- DRMA United States
- Employees
- NUWE N/A
- DRMA N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- NUWE Health Care
- DRMA Health Care
- Exchange
- NUWE Nasdaq
- DRMA Nasdaq
- Market Cap
- NUWE 5.2M
- DRMA 6.1M
- IPO Year
- NUWE N/A
- DRMA 2021
- Fundamental
- Price
- NUWE $0.94
- DRMA $1.04
- Analyst Decision
- NUWE Strong Buy
- DRMA Strong Buy
- Analyst Count
- NUWE 1
- DRMA 1
- Target Price
- NUWE $17.00
- DRMA $6.00
- AVG Volume (30 Days)
- NUWE 85.0K
- DRMA 4.1M
- Earning Date
- NUWE 03-11-2025
- DRMA 05-14-2025
- Dividend Yield
- NUWE N/A
- DRMA N/A
- EPS Growth
- NUWE N/A
- DRMA N/A
- EPS
- NUWE N/A
- DRMA N/A
- Revenue
- NUWE $8,740,000.00
- DRMA N/A
- Revenue This Year
- NUWE $30.31
- DRMA N/A
- Revenue Next Year
- NUWE $30.06
- DRMA N/A
- P/E Ratio
- NUWE N/A
- DRMA N/A
- Revenue Growth
- NUWE N/A
- DRMA N/A
- 52 Week Low
- NUWE $0.90
- DRMA $1.00
- 52 Week High
- NUWE $14.35
- DRMA $6.66
- Technical
- Relative Strength Index (RSI)
- NUWE 30.44
- DRMA 40.68
- Support Level
- NUWE $0.91
- DRMA $1.05
- Resistance Level
- NUWE $1.03
- DRMA $2.37
- Average True Range (ATR)
- NUWE 0.07
- DRMA 0.16
- MACD
- NUWE -0.02
- DRMA -0.01
- Stochastic Oscillator
- NUWE 16.13
- DRMA 2.65
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.